NCBI PubMed Central
open access
Influencing factors and model predictive analysis of the efficacy of adjuvant ¹³¹I therapy after DTC surgery.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma#1152646
- Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment#454024
- Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery#1173276
- Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer#862471
- Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients#842318
Record · ID 402608
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive